Scientists in the Russian city of Novosibirsk have created a vaccine that can double a cancer patient’s life expectancy. The drug has already been tested clinically and may soon appear in stores.
When given to patients suffering from the third and fourth stage of colorectal, breast and prostate cancer, the treatment can significantly prolong their life span, says Vladimir Kozlov, the head of the Clinical Immunology Institute that did the research.
The vaccine is extracted from the dendritic cells, which are immune cells producing antigen material. The patient’s dendritic cells are then altered with the tumor cell culture and injected into the organizm, triggering an immune response, which means they attack cancer.
The treatment is now available to people after a cancer surgery, although scientists envisage the drug would be able to cure cancer in the early stages.
Filed under: Uncategorized
